KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Gross Margin (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Gross Margin for 17 consecutive years, with 49.8% as the latest value for Q4 2025.

  • Quarterly Gross Margin fell 144.0% to 49.8% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 51.87% through Dec 2025, down 186.0% year-over-year, with the annual reading at 51.87% for FY2025, 186.0% down from the prior year.
  • Gross Margin for Q4 2025 was 49.8% at Bio-Rad Laboratories, down from 52.59% in the prior quarter.
  • The five-year high for Gross Margin was 58.43% in Q3 2021, with the low at 49.8% in Q4 2025.
  • Average Gross Margin over 5 years is 54.21%, with a median of 54.07% recorded in 2022.
  • The sharpest move saw Gross Margin skyrocketed 240bps in 2022, then crashed -396bps in 2023.
  • Over 5 years, Gross Margin stood at 54.57% in 2021, then decreased by 0bps to 54.37% in 2022, then decreased by -1bps to 53.77% in 2023, then fell by -5bps to 51.24% in 2024, then decreased by -3bps to 49.8% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 49.8%, 52.59%, and 52.99% for Q4 2025, Q3 2025, and Q2 2025 respectively.